Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY currently manages 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 5 distinct examiners working across 3 distinct art units. The distribution shows a one-to-one ratio between pending actions and examiners. The presence of 3 distinct art units indicates that the foundation's biotechnology research is being evaluated by several different specialized groups.
The busiest examiner for the foundation is BLEVINS, JERRY M, who handles 1 pending office action. Because each of the 5 distinct examiners is responsible for exactly one of the 5 pending office actions, the prosecution workload is fully decentralized among the assigned staff. Practitioners will need to coordinate with five different examiners across these three units to manage the current portfolio. This variety of examiners and units suggests that the foundation's 5 pending office actions cover a range of specific sub-disciplines within the Biotechnology & Pharmaceuticals field. Practitioners should expect to manage five separate examiner relationships without any overlap in current workloads.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLEVINS, JERRY M | 1 | 87.5% | +5.0% |
| PERENY, TYLER J | 1 | 95.0% | +5.9% |
| WASIL, DANIEL D | 1 | 79.9% | +24.7% |
| CORNET, JEAN P | 1 | 42.1% | +47.5% |
| ROGERS, ERIC JASON | 1 | 57.4% | +32.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18792474 | PREAMPLIFIER WITH ACTIVE DEADTIME CONTROL CIRCUIT AND METHOD FOR DRIVING THE SAME | PERENY, TYLER J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006684 | COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT | ROGERS, ERIC JASON | 21d |
| 18894010 | FIBER-OPTIC CABLE MAGNETIC COUPLING ADAPTER | BLEVINS, JERRY M | — |
| 18700700 | HIGH-DEFINITION EMISSION TOMOGRAPHY IMAGE ACQUISITION DEVICE FOR HIGH DENSITY FUEL ASSEMBLY | WASIL, DANIEL D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025433 | METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR | CORNET, JEAN P | 19d |
| 18006684 | COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT | ROGERS, ERIC JASON | 21d |
| 18700700 | HIGH-DEFINITION EMISSION TOMOGRAPHY IMAGE ACQUISITION DEVICE FOR HIGH DENSITY FUEL ASSEMBLY | WASIL, DANIEL D | — |
| Art Unit | Apps |
|---|---|
| 3646 | 1 |
| 1628 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18894010 | FIBER-OPTIC CABLE MAGNETIC COUPLING ADAPTER | BLEVINS, JERRY M | — | §102§103§112 | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18792474 | PREAMPLIFIER WITH ACTIVE DEADTIME CONTROL CIRCUIT AND METHOD FOR DRIVING THE SAME | PERENY, TYLER J | — | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18700700 | HIGH-DEFINITION EMISSION TOMOGRAPHY IMAGE ACQUISITION DEVICE FOR HIGH DENSITY FUEL ASSEMBLY | WASIL, DANIEL D | 3646 | §103§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18025433 | METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR | CORNET, JEAN P | 1628 | §103 | Non-Final OA | 19d | Pending | Mar 09, 2023 |
| 18006684 | COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT | ROGERS, ERIC JASON | 1638 | §103§112 | Final Rejection | 21d | Pending | Jan 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial